Fruth Investment Management Pfizer Inc Transaction History

Fruth Investment Management

$363 Million
Q4 2024

A detailed history of Fruth Investment Management transactions in Pfizer Inc stock. As of the latest transaction made, Fruth Investment Management holds 28,473 shares of PFE stock, worth $726,915. This represents 0.21% of its overall portfolio holdings.

Number of Shares

28,473

Previous 29,098 2.15%

Holding current value

$726,915

Previous $842,000 10.33%

% of portfolio

0.21%

Previous 0.22%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$24.8 - $30.19 $15,500 - $18,868	-625 Reduced 2.15%	28,473 $755,000
Q3 2024 Oct 11, 2024	SELL	$27.7 - $31.39 $13,850 - $15,695	-500 Reduced 1.69%	29,098 $842,000
Q1 2024 Apr 19, 2024	BUY	$25.89 - $29.73 $51,780 - $59,460	2,000 Added 7.25%	29,598 $821,000
Q4 2023 Jan 18, 2024	SELL	$26.13 - $33.94 $23,517 - $30,545	-900 Reduced 3.16%	27,598 $794,000
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $13,638 - $15,941	-425 Reduced 1.47%	28,498 $945,000
Q2 2023 Jul 25, 2023	SELL	$36.12 - $41.79 $3,611 - $4,179	-100 Reduced 0.34%	28,923 $1.06 Million
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $15,948 - $20,819	-382 Reduced 1.3%	29,023 $1.49 Million
Q3 2022 Oct 13, 2022	SELL	$43.76 - $53.42 $1,925 - $2,350	-44 Reduced 0.15%	29,405 $1.29 Million
Q2 2022 Jul 19, 2022	BUY	$46.53 - $55.17 $7,491 - $8,882	161 Added 0.55%	29,449 $1.54 Million
Q1 2022 Apr 12, 2022	SELL	$45.75 - $56.69 $1,143 - $1,417	-25 Reduced 0.09%	29,288 $1.52 Million
Q4 2021 Jan 14, 2022	BUY	$41.32 - $61.25 $8,264 - $12,250	200 Added 0.69%	29,313 $1.73 Million
Q3 2021 Oct 12, 2021	SELL	$39.25 - $50.42 $7,850 - $10,084	-200 Reduced 0.68%	29,113 $1.25 Million
Q2 2021 Jul 19, 2021	BUY	$35.91 - $40.68 $28,189 - $31,933	785 Added 2.75%	29,313 $1.15 Million
Q1 2021 Apr 14, 2021	SELL	$33.49 - $37.77 $3,683 - $4,154	-110 Reduced 0.38%	28,528 $1.03 Million
Q4 2020 Jan 13, 2021	BUY	$33.47 - $42.56 $13,388 - $17,024	400 Added 1.42%	28,638 $1.05 Million
Q3 2020 Oct 07, 2020	BUY	$31.75 - $37.25 $479,425 - $562,475	15,100 Added 114.93%	28,238 $1.04 Million
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $837 - $1,197	-31 Reduced 0.24%	13,138 $428,000
Q4 2019 Jan 10, 2020	BUY	$32.92 - $37.36 $3,292 - $3,736	100 Added 0.77%	13,169 $515,000
Q3 2019 Oct 09, 2019	SELL	$32.49 - $42.13 $11,371 - $14,745	-350 Reduced 2.61%	13,069 $469,000
Q2 2019 Jul 15, 2019	SELL	$36.98 - $41.52 $1,848 - $2,076	-50 Reduced 0.37%	13,419 $581,000
Q1 2019 Apr 16, 2019	SELL	$37.5 - $41.2 $36,750 - $40,376	-980 Reduced 6.78%	13,469 $572,000
Q4 2018 Jan 16, 2019	SELL	$38.47 - $43.86 $23,082 - $26,316	-600 Reduced 3.99%	14,449 $630,000
Q3 2018 Oct 10, 2018	BUY	$34.47 - $41.81 $13,788 - $16,724	400 Added 2.73%	15,049 $663,000
Q2 2018 Jul 23, 2018	SELL	$32.98 - $35.16 $8,607 - $9,176	-261 Reduced 1.75%	14,649 $531,000
Q1 2018 May 01, 2018	SELL	$31.91 - $37.02 $3,191 - $3,702	-100 Reduced 0.67%	14,910 $529,000
Q4 2017 Jan 09, 2018	SELL	$33.26 - $35.29 $6,652 - $7,058	-200 Reduced 1.31%	15,010 $543,000
Q3 2017 Oct 12, 2017	BUY	$31.0 - $34.15 $471,510 - $519,421	15,210	15,210 $542,000

Others Institutions Holding PFE

# of Institutions

3,329

Shares Held

3.68B

Call Options Held

101M

Put Options Held

131M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $143B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fruth Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Fruth Investment Management with notifications on news.

Account

Fruth Investment Management Pfizer Inc Transaction History